Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
UBS
Accenture
McKinsey
QuintilesIMS
Merck
Baxter
AstraZeneca

Generated: June 20, 2018

DrugPatentWatch Database Preview

CHLOROTRIANISENE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Chlorotrianisene, and when can generic versions of Chlorotrianisene launch?

Chlorotrianisene is a drug marketed by Banner Pharmacaps and is included in one NDA.

The generic ingredient in CHLOROTRIANISENE is chlorotrianisene. There are four drug master file entries for this compound. Additional details are available on the chlorotrianisene profile page.
Summary for CHLOROTRIANISENE
Drug patent expirations by year for CHLOROTRIANISENE
Medical Subject Heading (MeSH) Categories for CHLOROTRIANISENE
Synonyms for CHLOROTRIANISENE
1-[1-chloro-2,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene
1-[2-chloro-1,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene
1-[2-Chloro-1,2-bis(4-methoxyphenyl)vinyl]-4-methoxybenzene #
1,1',1''-(1-Chloro-1-ethenyl-2-ylidene)-tris(4-methoxybenzene)
1,1',1''-(2-chloroethene-1,1,2-triyl)tris(4-methoxybenzene)
1,1',1''-(2-chloroethene-1,1,2-triyl)tris[4-(methyloxy)benzene]
1,1',1''(1-Chloro-1-ethenyl-2-ylidene)tris[4-methoxybenzene]
162370-EP2280006A1
162370-EP2281813A1
4-06-00-07650 (Beilstein Handbook Reference)
4,4',4''-(2-chloroethene-1,1,2-triyl)tris(methoxybenzene)
569-57-3
569C573
6V5034L121
AB00051941
AC-12512
AC1L1X1E
AC1Q3FDW
AKOS015960863
Anisene
API0001964
B5912
BC204747
Benzene, 1,1',1'-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy)-
Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy-
Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy)-
Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris[4-methoxy-
Benzene,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris[4-methoxy-
BFPSDSIWYFKGBC-UHFFFAOYSA-N
BPBio1_000852
BRN 1891845
BSPBio_000774
BSPBio_002005
C-50387
CAS-569-57-3
CCG-40079
CCRIS 4769
CHEBI:3641
CHEMBL1200761
Chloortrianisestrol
Chlorestrolo
Chlorotrianisene (INN)
Chlorotrianisene [BAN:INN]
Chlorotrianisene [INN:BAN]
Chlorotrianisene [Nonsteroidal oestrogens]
CHLOROTRIANISENE CRYSTALLINE
Chlorotrianisene, ~95%
Chlorotrianisenum
Chlorotrianisenum [INN-Latin]
chlorotrianisestrol
Chlorotrianisine
Chlorotrianizen
Chlorotris(p-methoxyphenyl)ethylene
Chlorotrisin
Chlortrianisen
Chlortrianisene
Chlortrianisenum
Chlortrianisestrol
Chlortrianisoestrolum
Chlortrianizen
CJ-23983
Clorestrolo
Clorotrianisene
Clorotrianisene [DCIT]
Clorotrianiseno
Clorotrianiseno [INN-Spanish]
Clorotrisin
D00269
D0X0KJ
DB00269
DSSTox_CID_1299
DSSTox_GSID_21299
DSSTox_RID_76067
DTXSID1021299
EINECS 209-318-6
Ethylene, chlorotris(p-methoxyphenyl)-
FT-0632409
GTPL7146
HMS1570G16
HMS1920K17
HMS2091C20
HMS2097G16
HMS2230L03
HMS3371E11
Hormonisene
HSDB 3302
KBio2_000596
KBio2_003164
KBio2_005732
KBio3_001225
KBioGR_001568
KBioSS_000596
Khlortrianizen
LS-226
Merbentul
Metace
MLS000028625
MLS002415722
MolPort-001-783-515
NCGC00016511-01
NCGC00016511-02
NCGC00016511-03
NCGC00016511-04
NCGC00016511-05
NCGC00016511-08
NCGC00091333-01
NCGC00091333-02
NCGC00091333-03
NCGC00256381-01
NCGC00259910-01
NSC-10108
NSC10108
Opera_ID_1728
OR008534
OR286687
Prestwick_22
Prestwick0_000757
Prestwick1_000757
Prestwick2_000757
Prestwick3_000757
Rianil
s4629
SBI-0051309.P003
SCHEMBL8225
SMR000058658
SPBio_000887
SPBio_002713
Spectrum_000136
SPECTRUM1500181
Spectrum2_000704
Spectrum3_000343
Spectrum4_000954
Spectrum5_000711
SR-01000721940
SR-01000721940-2
TACE
Tace (pharmaceutical)
TACE (TN)
Tace-fn
Tox21_110466
Tox21_110466_1
Tox21_202361
Tox21_302897
Tri-p-anisylchloroethylene
Triagen
Trianisestrol
Tris(p-methoxyphenyl)chloroethylene
UNII-6V5034L121
WLN: 1OR DYGUYR DO1&R DO1
ZINC1530598

US Patents and Regulatory Information for CHLOROTRIANISENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Banner Pharmacaps CHLOROTRIANISENE chlorotrianisene CAPSULE;ORAL 084652-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Covington
Chinese Patent Office
Healthtrust
Boehringer Ingelheim
Argus Health
Medtronic
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.